Samrat S. Khichi

Insider

First SEC filing: April 2, 2026 · Latest: April 2, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Initial holdings The stakes this person held when they first started reporting.
Compensation Executive pay disclosed in company proxy statements.

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 26 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

26 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
April 1, 2026	CVS	F	3,541	$72.49	$256,687	33,421 Direct	-9.58%	Disposed	29.7% (price as of 2026-08-20)
March 31, 2026	CVS	A	80,838	$71.82	$5,805,785	80,838 Direct	—	Acquired	30.9% (price as of 2026-08-20)
March 31, 2026	CVS	A	12,531	$71.82	$899,976	38,139 Direct	+48.93%	Acquired	30.9% (price as of 2026-08-20)
Feb. 28, 2026	CVS	F	7,886	$79.60	$627,726	29,775 Direct	-20.94%	Disposed	18.1% (price as of 2026-08-20)
April 1, 2025	CVS	A	68,621	$67.98	$4,664,856	68,621 Direct	—	Acquired	38.3% (price as of 2026-08-20)
April 1, 2025	CVS	A	16,181	$67.98	$1,099,984	41,569 Direct	+63.73%	Acquired	38.3% (price as of 2026-08-20)
April 1, 2025	CVS	F	1,548	$67.98	$105,233	21,700 Direct	-6.66%	Disposed	38.3% (price as of 2026-08-20)
Feb. 28, 2025	CVS	F	5,604	$65.72	$368,295	20,106 Direct	-21.80%	Disposed	43.1% (price as of 2026-08-20)
April 1, 2024	CVS	A	52,246	$79.56	$4,156,692	52,246 Direct	—	Acquired	18.2% (price as of 2026-08-20)
April 1, 2024	CVS	A	12,569	—	—	44,490 Direct	+39.38%	Acquired	(price as of 2026-08-20)
Feb. 28, 2024	CVS	F	6,210	$75.19	$466,930	9,750 Direct	-38.91%	Disposed	25.1% (price as of 2026-08-20)
April 1, 2023	CVS	A	66,805	$74.31	$4,964,280	66,805 Direct	—	Acquired	26.6% (price as of 2026-08-20)
Feb. 28, 2023	CVS	A	47,881	$83.54	$3,999,979	47,881 Direct	—	Acquired	12.6% (price as of 2026-08-20)
Dec. 21, 2022	BDX	G	19	—	—	9,251 Direct	-0.20%	Disposed	(price as of 2026-08-20)
Dec. 13, 2022	BDX	G	40	—	—	9,270 Direct	-0.43%	Disposed	(price as of 2026-08-20)
Nov. 26, 2022	BDX	A	12,484	—	—	12,484 Direct	—	Acquired	(price as of 2026-08-20)
Nov. 26, 2022	BDX	F	1,908	—	—	9,310 Direct	-17.01%	Disposed	(price as of 2026-08-20)
Nov. 26, 2022	BDX	A	1,956	—	—	11,218 Direct	+21.12%	Acquired	(price as of 2026-08-20)
Nov. 26, 2022	BDX	A	3,334	—	—	9,262 Direct	+56.24%	Acquired	(price as of 2026-08-20)
Aug. 9, 2022	BDX	M	12,489	—	—	0 Direct	—	Acquired	(price as of 2026-08-20)
Aug. 9, 2022	BDX	M	14,326	—	—	0 Direct	—	Acquired	(price as of 2026-08-20)
Aug. 9, 2022	BDX	D	5,194	$260.44	$1,352,725	13,223 Direct	-28.20%	Disposed	-8.5% (price as of 2026-08-20)
Aug. 9, 2022	BDX	M	12,489	$108.25	$1,351,934	18,417 Direct	+210.68%	Acquired	120.2% (price as of 2026-08-20)
Aug. 9, 2022	BDX	S 10b5-1	9,185	$260.44	$2,392,141	5,928 Direct	-60.78%	Disposed	-8.5% (price as of 2026-08-20)
Aug. 9, 2022	BDX	D	5,141	$260.44	$1,338,922	15,113 Direct	-25.38%	Disposed	-8.5% (price as of 2026-08-20)
Aug. 9, 2022	BDX	M	14,326	$93.49	$1,339,338	20,254 Direct	+241.67%	Acquired	155.0% (price as of 2026-08-20)
Aug. 8, 2022	BDX	S 10b5-1	7,295	$260.44	$1,899,910	5,928 Direct	-55.17%	Disposed	-8.5% (price as of 2026-08-20)
Feb. 8, 2022	BDX	G	375	—	—	5,928 Direct	-5.95%	Disposed	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
March 31, 2026	CVS	Stock Option [F3]	Common Stock (80,838)	$71.82	March 31, 2036	80,838	Acquired
April 1, 2025	CVS	Stock Option [F3]	Common Stock (68,621)	$67.98	April 1, 2035	68,621	Acquired
April 1, 2024	CVS	Stock Option	Common Stock (52,246)	$79.56	April 1, 2034	52,246	Acquired
April 1, 2023	CVS	Stock Option [F1]	Common Stock (66,805)	$74.31	April 1, 2033	66,805	Acquired
Nov. 26, 2022	BDX	Stock Appreciation Rights	Common Stock (12,484)	$238.06	Nov. 26, 2032	12,484	Acquired
Aug. 9, 2022	BDX	Stock Appreciation Rights	Common Stock (12,489)	—	Dec. 10, 2024	12,489	Acquired
Aug. 9, 2022	BDX	Stock Appreciation Rights	Common Stock (14,326)	—	July 16, 2024	14,326	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 5 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
Jan. 3, 2018	BDX	Common Stock	29,758	Direct
Jan. 3, 2018	BDX	Stock Appreciation Rights→ Common Stock (14,093)	14,093	Direct
Jan. 3, 2018	BDX	Stock Appreciation Rights→ Common Stock (12,286)	12,286	Direct
Jan. 3, 2018	BDX	Stock Appreciation Rights→ Common Stock (14,822)	14,822	Direct
Jan. 3, 2018	BDX	Stock Appreciation Rights→ Common Stock (12,505)	12,505	Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

BDX

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2020	$627,000	$1,051,343	$926,683	—	$455,400	$201,582	$59,538	$3,482,596

CVS

General Counsel

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2023	$753,409	$2,000,000	$7,374,948	$1,124,996	$626,000	—	$7,150	$11,886,503

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.